What Happens Before a Skin-Contact Product Is Released for Sale?

A finished bottle sitting on a shelf can make manufacturing look deceptively simple.

Ingredients go in.

A product comes out.

A label goes on.

Ship it.

In a well-controlled manufacturing process, however, there can be numerous steps between receiving raw materials and deciding that a finished batch is suitable for distribution.

Those steps may include material identification, manufacturing records, in-process controls, laboratory testing, packaging checks, documentation review, and final disposition of the batch.

The exact process varies considerably with the product and manufacturer.

But the underlying question is remarkably consistent:

Do we have sufficient evidence that this batch is what we intended to manufacture and that it meets the requirements established for it?

That question is at the heart of product release.

Step 1: The Raw Materials Arrive

Manufacturing begins before anything is mixed.

Ingredients and packaging materials first have to arrive at the manufacturing facility.

At that point, an appropriate material-control system may consider things such as:

supplier identity;
material identity;
lot or batch number;
condition of the container;
labeling;
storage requirements;
documentation;
and applicable acceptance specifications.

FDA's cosmetic GMP inspection guidance specifically addresses identification and lot status of raw materials, protection against contamination and deterioration, and examination or testing where appropriate. Materials that do not meet acceptance specifications should be controlled to prevent their unintended use.

In other words, an ingredient shouldn't become acceptable merely because a drum bearing its name arrived at the loading dock.

Step 2: Materials Are Identified and Controlled

One deceptively important part of manufacturing is knowing the status of a material.

Has it been accepted?

Is it awaiting examination?

Has it been rejected?

Is it the correct lot?

Without an organized system, materials that look similar can potentially be confused or used incorrectly.

FDA's cosmetic GMP guidance therefore discusses labeling materials with identity, lot identification, and control status, as well as preventing rejected materials from being inadvertently used.

This introduces an important manufacturing principle:

Knowing what something is isn't enough. You also need to know whether it is authorized for use.

Step 3: The Batch Is Prepared According to Manufacturing Instructions

Once approved materials are available, production can begin.

A controlled manufacturing process ordinarily works from established instructions rather than relying on someone's memory of how the product was made last time.

Documentation may identify:

the formulation;
ingredients and quantities;
material lot numbers;
processing sequence;
mixing or processing requirements;
transfer procedures;
filling instructions;
in-process controls;
and batch identification.

FDA's GMP material calls for established written manufacturing and control instructions and records documenting the materials and lots used, processing, handling, transferring, holding, filling, sampling, adjustments, and finished-product code marks.

That's an enormous part of reproducibility.

A successful formula isn't particularly useful commercially if nobody can reliably manufacture it again.

Step 4: Manufacturing Is Documented

Good documentation answers a deceptively simple question:

What actually happened?

There is a difference between:

“This is how we normally manufacture the product.”

and:

“This is what occurred when batch 26A417 was manufactured.”

Batch records can connect a particular finished production run with the raw-material lots and processing steps used to make it.

FDA's GMP guidance describes records documenting material kinds, lots and quantities, processing and filling, sampling and control activities, and batch or finished-product codes.

That information becomes particularly important if a question arises months later.

Step 5: Checks May Occur During Manufacturing

Quality control doesn't necessarily wait until production is finished.

Depending upon the formulation and process, manufacturers may perform in-process checks.

These can help determine whether manufacturing is proceeding as intended.

An in-process check might concern a relevant characteristic such as:

appearance;
pH;
viscosity;
temperature;
weight;
mixing uniformity;
fill quantity;
or another process-specific parameter.

Which checks are appropriate depends upon the product.

FDA's GMP guidance specifically contemplates in-process sampling and controls as part of manufacturing and laboratory oversight.

The advantage is obvious:

If something is going wrong, it is often better to discover it during manufacturing than after thousands of finished units have been packaged.

Step 6: The Finished Product Is Evaluated

Eventually the manufacturing process produces a finished batch.

But finished does not necessarily mean released.

Samples may be examined or tested against established finished-product specifications.

Depending upon the product, relevant characteristics might include:

appearance;
odor;
color;
pH;
viscosity;
specific gravity;
chemical characteristics;
microbiological quality;
fill or package characteristics;
or other established requirements.

FDA's cosmetic GMP guidance discusses testing or examining finished products for compliance with applicable physical, chemical, microbiological, and contaminant specifications.

Not every product requires every test.

The testing program should make sense for the formulation and its risks.

Step 7: Microbiological Considerations May Be Evaluated

Microbiological control is particularly relevant for formulations that can support microbial growth.

Contamination can potentially originate from raw materials, water, manufacturing conditions, ineffective preservation, packaging, storage, or even later consumer use.

That does not mean every cosmetic must be sterile.

FDA explicitly states that cosmetics do not have to be sterile, but they must not contain harmful microorganisms.

Water-containing formulations can present different microbiological considerations from substantially anhydrous products, so testing and preservation strategies should be appropriate to the formulation.

This is another recurring theme in responsible manufacturing:

The control should fit the risk.

Step 8: Packaging Is Part of the Product

Quality doesn't stop when the formulation leaves the mixing vessel.

The package matters too.

Packaging has practical jobs:

containing the product;
protecting it during storage and transport;
allowing appropriate dispensing;
limiting contamination where relevant;
and carrying required product information.

FDA notes that inadequate packaging can be one route by which a cosmetic becomes microbiologically contaminated.

Packaging materials also need to be properly identified and controlled. FDA's GMP guidance addresses both raw materials and primary packaging materials, along with controls intended to prevent mix-ups and contamination.

The bottle isn't merely decoration surrounding the formulation.

It participates in protecting it.

Step 9: The Label Is Checked

Putting the wrong label on the right product can create a serious quality problem.

The label communicates information about what the product is and how it should be used.

Manufacturing controls therefore need to reduce the possibility of:

incorrect labels;
label mix-ups;
incorrect packaging;
missing information;
or incorrect lot identification.

FDA's GMP guidance specifically addresses label examination and control and permanent code marks on finished packages.

This is an excellent example of why quality control extends beyond laboratory chemistry.

A laboratory can test a formulation perfectly and still cannot compensate for putting it in the wrong package.

Step 10: The Lot Is Identified

Lot or batch identification provides a link between the physical product in a customer's hand and its manufacturing history.

That identifier can potentially connect the product with:

finished unit → finished batch → manufacturing record → raw-material lots → testing records

That is traceability.

FDA's GMP guidance calls for code marks on finished packages and manufacturing records linking batches with their production and laboratory control information.

Traceability becomes particularly important if a complaint, investigation, or recall occurs later.

Without it, determining which production is affected becomes much harder.

Step 11: The Records Are Reviewed

This is one of the least visible but most important parts of the process.

A finished batch can have perfectly attractive packaging while its manufacturing record contains an unresolved discrepancy.

So product release shouldn't depend simply upon how the finished product looks.

The relevant information may need to be reviewed:

Were the correct materials used?
Were the correct quantities documented?
Were required manufacturing steps completed?
Were in-process checks acceptable?
Did finished-product results meet specifications?
Were deviations documented?
Were packaging and labels correct?
Is anything unresolved?

FDA's draft cosmetic GMP guidance discusses evaluating laboratory records and documenting whether raw materials, in-process materials, and finished products were accepted or rejected.

This review converts a collection of manufacturing records into a decision.

Step 12: The Batch Receives a Disposition

Eventually somebody has to answer:

What happens to this batch?

Broadly speaking, its status might become something such as:

accepted / released

rejected / held for further investigation

depending upon the manufacturer's procedures and circumstances.

FDA's draft GMP material specifically discusses documenting finished-product control status as accepted or rejected.

This is the point at which an important distinction becomes useful:

Manufactured is not the same as released.

Production creates the batch.

The quality system determines whether the batch satisfies the established conditions for disposition.

What Happens If Something Doesn't Look Right?

A mature quality system does not depend upon pretending that nothing unexpected ever happens.

Things happen.

A measurement may fall outside its expected range.

An ingredient quantity may need investigation.

Packaging may be incorrect.

A piece of equipment may malfunction.

A laboratory result may be unexpected.

The meaningful question is:

What does the manufacturer do when something unexpected occurs?

Depending upon the situation, the product might be held while the issue is investigated.

The investigation may determine that the batch is acceptable, requires appropriate corrective action, or should be rejected.

What should not happen is simply ignoring inconvenient information because the product is already manufactured.

Does “Released” Mean FDA Approved?

No.

This is worth making exceptionally clear.

Cosmetic products and ingredients generally do not require FDA approval before being marketed in the United States. Color additives are an important exception and are subject to specific approval requirements.

When we say a manufacturer releases a batch, we are describing an internal manufacturing and quality decision.

We are not saying:

“FDA inspected this batch and approved it.”

Those are entirely different concepts.

What About Product Safety?

Batch quality control and product safety are related, but they aren't identical.

Before a company markets a cosmetic, there should also be an adequate scientific basis supporting its safety under its intended or customary conditions of use.

Under MoCRA, the responsible person must ensure and maintain records supporting adequate substantiation of safety. FDA does not prescribe one specific safety test that every cosmetic must undergo.

That means safety evaluation may draw upon:

ingredient safety information;
toxicological data;
historical information;
exposure considerations;
formulation knowledge;
published scientific literature;
and additional testing when necessary.

A finished-product QC result is therefore one piece of a larger picture.

What Happens After Release?

Quality responsibility doesn't disappear when the truck leaves the loading dock.

Manufacturers and responsible persons may continue receiving information from:

customer complaints;
product returns;
stability programs;
retained samples;
distributors;
adverse-event reports;
and marketplace experience.

MoCRA also requires responsible persons to report serious adverse events associated with cosmetic products to FDA within the statutory timeframe and maintain related records.

Post-market information can sometimes reveal something that wasn't apparent during production.

So quality isn't merely:

make → test → ship → forget.

It is a lifecycle.

From Raw Material to Released Product

Viewed as a whole, a controlled manufacturing journey might look something like this:

Raw materials received

↓

Materials identified and controlled

↓

Accepted materials issued to production

↓

Batch manufactured according to established instructions

↓

In-process checks performed where appropriate

↓

Finished product sampled and evaluated

↓

Packaging and labeling verified

↓

Manufacturing and laboratory records reviewed

↓

Batch disposition determined

↓

Released product enters distribution

That sequence won't be identical for every manufacturer or every product.

But it illustrates the larger point:

A responsible release decision should be based upon evidence accumulated throughout manufacturing—not simply upon the fact that production has finished.

Why Should a Customer Care About Any of This?

Because most of this work is invisible.

When you purchase a skin-contact product, you generally cannot look at it and determine:

whether the correct raw materials were used;
whether those materials were traceable;
whether the manufacturing process was documented;
whether relevant specifications were met;
whether contamination controls were appropriate;
or whether someone reviewed the manufacturing history before release.

The customer sees the final package.

The quality system is what stands behind it.

That is why meaningful manufacturing quality is rarely one dramatic test or certification.

It is the accumulation of many comparatively ordinary controls, performed consistently, documented properly, and taken seriously.

And when a product is intended to come into contact with skin, those quiet steps matter.

What Does Good Manufacturing Practice Mean for Products Used on Skin?

Why Quality Control Matters for Products Used on Skin

Why Raw Material Quality Matters in Skin-Contact Products

How Manufacturers Help Control Contamination

What Do Certifications Really Tell You About a Product?

Sources

U.S. Food and Drug Administration. Good Manufacturing Practice (GMP) Guidelines/Inspection Checklist for Cosmetics. Covers raw-material identification and control, written production instructions, in-process controls, laboratory testing, retained samples, manufacturing records, finished-product records, labels, code marks and storage.
U.S. Food and Drug Administration. Draft Guidance for Industry: Cosmetic Good Manufacturing Practices. Discusses batch documentation, ingredients and lot numbers, production steps, in-process controls, finished-product control status, laboratory records and records sufficient to support effective recalls. FDA identifies this guidance as nonbinding and draft.
U.S. Food and Drug Administration. Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Current FDA overview of safety substantiation, facility registration, product listing, adverse-event reporting, records access and FDA's cosmetics authorities.
U.S. Food and Drug Administration. Product Testing of Cosmetics. Discusses safety testing, microbiological considerations and manufacturer responsibility for cosmetic-product safety.
U.S. Food and Drug Administration. Microbiological Safety and Cosmetics. Describes possible contamination routes including raw materials, water, manufacturing conditions, preservation, packaging, shipping, storage and consumer use.
International Organization for Standardization. ISO 22716:2007 — Cosmetics — Good Manufacturing Practices (GMP). International GMP guidelines covering production, control, storage and shipment of cosmetic products.